Kidiamix G (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Kidiamix G, an amino acid solution for parenteral nutrition, supports patients who cannot receive enteral feeding.

• Parenteral nutrition: provides a complete amino acid profile to maintain protein synthesis in patients unable to eat orally or enterally.
• Post‑operative care: supplies essential amino acids to aid recovery after major surgery.
• Critical care/trauma: helps maintain nitrogen balance in severely ill or injured patients.

• Kidiamix G delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. These amino acids are taken up by cells and incorporated into proteins, supporting tissue repair, enzyme synthesis, and maintaining nitrogen balance. By bypassing the gastrointestinal tract, the solution ensures rapid availability of substrates for metabolic processes in patients receiving parenteral nutrition.

Kidiamix G may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects

• Phlebitis at infusion site: mild inflammation of the vein used for administration.
• Mild hypernatremia: slight increase in serum sodium levels.
• Transient rise in blood urea nitrogen: temporary elevation reflecting protein metabolism.
• Mild metabolic alkalosis: slight shift in acid‑base balance.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical attention.
• Severe hyperammonemia: dangerous accumulation of ammonia in the blood.
• Electrolyte disturbances (e.g., hyperkalemia): significant changes in serum electrolytes.
• Catheter‑related infection: infection at the intravenous access site.

Kidiamix G requires careful monitoring in specific clinical situations.

• Renal impairment: monitor renal function and adjust amino acid load as needed.
• Liver disease: watch for ammonia accumulation and adjust therapy accordingly.
• Electrolyte imbalance: regularly check serum electrolytes during treatment.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant.
• Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G can interact with certain medications and solutions.

Major Interactions (Avoid)

• Concurrent high‑dose nitrogenous waste products: may exacerbate hyperammonemia.
• Incompatible IV solutions (e.g., calcium‑containing solutions): can precipitate and cause emboli.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may increase loss of electrolytes, requiring close monitoring.
• Insulin therapy: amino acids stimulate insulin release, potentially affecting glucose control.
• Other parenteral nutrition components: balance of dextrose and lipids should be coordinated to avoid metabolic overload.